Entry

D07507            Mixture   Drug

Name

Zidovudine and lamivudine;
Combivir (TN);
Lamivudine zidovudine (TN)

Product

COMBIVIR (ViiV Healthcare Company)

Generic

LAMIVUDINE AND ZIDOVUDINE (American Health Packaging), LAMIVUDINE AND ZIDOVUDINE (Aurobindo Pharma Limited), LAMIVUDINE AND ZIDOVUDINE (Aurobindo Pharma Limited), LAMIVUDINE AND ZIDOVUDINE (AvPAK), LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack), LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack), LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack), LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack), LAMIVUDINE AND ZIDOVUDINE (Camber Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (Camber Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (Exelan Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (Lupin Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (Macleods Pharmaceuticals Limited), LAMIVUDINE AND ZIDOVUDINE (NuCare Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (PD-Rx Pharmaceuticals), LAMIVUDINE AND ZIDOVUDINE (Strides Pharma Science Limited), LAMIVUDINE AND ZIDOVUDINE (XLCare Pharmaceuticals)

Component

Zidovudine [DR:D00413], Lamivudine [DR:D00353]

Class

Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG03107 Anti-HIV agent

Remark

Therapeutic category:

6250

ATC code:

J05AR01

Product:

D07507<JP/US>

Efficacy

Antiviral

Disease

HIV-1 infection [DS:H01563]

Target

HIV-1 reverse transcriptase [KO:K24802]

Pathway

ko03230

Viral genome structure

ko03240

Viral replication

ko03250

Viral life cycle - HIV-1

Interaction

Brite

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR01 Zidovudine and lamivudine
      D07507  Zidovudine and lamivudine <JP/US>
USP drug classification [BR:br08302]
Antivirals
  Anti-HIV Combinations
   Lamivudine/ Zidovudine
    D07507  Zidovudine and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D07507  Zidovudine and lamivudine
Drug groups [BR:br08330]
Antiviral
  DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
   D07507  Zidovudine and lamivudine
  DG03107  Anti-HIV agent
   D07507  Zidovudine and lamivudine
Drug classes [BR:br08332]
Antiviral
  DG03107  Anti-HIV agent
   D07507  Zidovudine and lamivudine
Antimicrobials [BR:br08307]
Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D07507  Zidovudine and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
  D07507

Other DBs

PubChem:

51091831